News
//72Results
Corporate
New CEO for Merz Therapeutics: Stefan König
Frankfurt am Main /
Mexico City, London, and now Frankfurt am Main, Germany: Experienced Pharma manager appointed to lead Merz Therapeutics As of immediately, Stefan König will be responsible for Merz Therapeutics GmbH as…
Read moreCorporate News
New CEO for Merz Consumer Care: Xenia Barth
Frankfurt am Main /
As an experienced manager for consumer beauty care marketing and sales, Xenia Barth is taking over the management of Merz Consumer Care. From now on, Xenia Barth will be responsible…
Read moreNeurotoxin
XEOMIN® (incobotulinumtoxinA) Receives European Approval for the Treatment of Chronic Sialorrhea in Children
Frankfurt, Germany /
First and only botulinum neurotoxin approved for this indication in Europe Today, Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, has been…
Read moreCorporate
Merz and Israeli start-up Vensica launch partnership for needleless treatment of overactive bladder
Frankfurt, Germany /
Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, and the Israeli start-up Vensica Therapeutics Ltd., a urology company, announced today that they…
Read moreNeurotoxin
Teijin Receives Additional Approval in Japan for Merz’s Xeomin® Botulinum Toxin Type A
Frankfurt, Germany /
Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, jointly…
Read moreCorporate
Merz Healthcare Breaks Even Despite COVID-19 Pandemic in Fiscal Year 2019/20
Frankfurt, Germany /
Net consolidated operating profit of the Frankfurt family business amounts to EUR 38.8 million Partnership with Gwyneth Paltrow and investment in start-up Brooklyn Soap Company Investments in the new organizational structure pay…
Read moreNeurotoxin
Teijin Receives Marketing Approval for Merz’s Xeomin®
Frankfurt am Main, Germany /
Merz Pharmaceuticals GmbH, a leading neurotoxin company and subsidiary of Merz Pharma GmbH & Co. KGaA, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, jointly…
Read moreCorporate
Merz Aesthetics appoints Samantha Kerr, Ph.D., as Chief Scientific Officer
Raleigh, NC, USA /
Merz Aesthetics, the largest dedicated medical aesthetics business globally, today announced the appointment of Samantha Kerr, Ph.D., as Chief Scientific Officer, effective March 16, 2020. As part of the company’s…
Read moreAesthetics
Merz Aesthetics Presents Data at the IMCAS World Congress 2020
Frankfurt, Germany /
Merz Aesthetics also recognizes 10th anniversary of BOCOUTURE® (incobotulinumtoxin A) in Europe. Merz, a global leader in medical aesthetics, announced today that data on the Merz Aesthetics product portfolio, including…
Read moreCorporate
Merz to Create Three Independent, Customer-Focused Businesses To Drive Growth
Frankfurt, Germany /
New organizational structure planned to strengthen customer focus and drive sustainable growth Merz names new CEOs dedicated to Aesthetics, Therapeutics and Consumer Care Achieved revenue of EUR 1,094 million in…
Read more